Publications

Search
Found 80 results
Filters: Author is Morgan,S. G.  [Clear All Filters]
2010
Cunningham CM, Hanley GE, Morgan SG. Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health policy (Amsterdam, Netherlands)Health Policy. 2010;97(2-3):122-129.
Morgan SG, Gagnon MA, Law M, Cunningham C, Kohler JC. Pharmaceutical industry employment in Canada: Levels, trends, and issues for consideration. Vancouver: Pharmaceutical Policy Research Collaboration; 2010.
Leong VW, Morgan SG, Wong ST, Hanley GE, Black CD. Registration for public drug benefits across areas of differing ethnic composition in British Columbia, Canada. BMC health services researchBMC Health Serv.Res.. 2010;10:171.
Greyson DL, Becu AR, Morgan SG. Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research. International journal for equity in healthInt.J.Equity Health.. 2010;9:26.
2009
Morgan SG, Cunningham C, Hanley G, Mooney D. BC Rx Atlas 2nd Edition (2009). 2nd Edition. UBC Centre for Health Services and Policy Research; 2009.
Morgan SG, Hanley G, Raymond C, Blais R. Breadth, Depth and Agreement Among Provincial Drug Formularies in Canada . Healthcare Policy. 2009;4(4):e162-e184.
Morgan SG, Hanley G, Raymond C, Blais R. Breadth, Depth and Agreement among Provincial Formularies in Canada. Healthcare policy = Politiques de santeHealthc.Policy.. 2009;4(4):e162-84.
Morgan SG, Cunningham C, Hanley G, Mooney D. British Columbia Medical and Hospital Atlas. Vancouver (BC): UBC Centre for Health Services and Policy Research; 2009.
Hanley GE, Morgan SG. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social science & medicine (1982)Soc.Sci.Med.. 2009;68(5):919-924.
Hanley G, Morgan SG. Chronic Catastrophes: Exploring the Concentration & Sustained Nature of Ambulatory Rx Drug Expenditures in the Population of BC. Social Science and Medicine. 2009.
Morgan SG, Hanley G, Greyson D. Comparing tiered formularies and reference pricing policies: A systematic review. Open Medicine. 2009;3(3).
Morgan SG, Kennedy J. Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Greyson D, Morgan SG, Hanley G, Wahyuni D. Open access archiving and article citations within health services and policy research. Journal of the Canadian Health Libraries Association. 2009;30(2):51-58.
Morgan SG, Kennedy J, Boothe K, McMahon M, Roughead E, Watson D. Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. The Open Health and Policy Journal. 2009;2:1-9.
Morgan SG, Mintzes B, Wright J. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS ONE. 2009;4(5).
2008
Morgan SG, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health policy (Amsterdam, Netherlands)Health Policy. 2008;87(2):133-145.
Morgan SG, Raymond CB, Mooney D, Martin D. The Canadian Rx Atlas, 2nd Edition. UBC Centre for Health Services and Policy Research; 2008.
Hanley GE, Morgan SG, Hurley J, van Doorslaer E. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Health economicsHealth Econ.. 2008;17(12):1379-1392.
Hanley GE, Morgan SG. On the validity of area-based income measures to proxy household income. BMC health services researchBMC Health Serv.Res.. 2008;8:79.
2007
Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatric services (Washington, D.C.)Psychiatr.Serv.. 2007;58(1):79-84.
Morgan SG. Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada. Open medicine : a peer-reviewed, independent, open-access journalOpen Med.. 2007;1(1):e37-45.
Morgan SG, Hanley G, McMahon M, Barer ML. Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):e121-40.
Morgan SG, Macgibbon B. Pharmaceutical use and outcomes: always a need for a sober second look. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):10-22.
Raymond CB, Morgan SG, Katz A, Kozyrskyj AL. A population-based analysis of statin utilization in British Columbia. Clinical therapeuticsClin.Ther.. 2007;29(9):2107-2119.
2006
Morgan SG, McMahon M, Mitton C. Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.

Pages